Skip to main content
Equibles

Jason Gerberry

Analyst

Bank of America

Equibles does not estimate personal net worth.

About Jason Gerberry

Jason Gerberry is recorded as Analyst at Bank of America. Jason Gerberry has spoken on 40 earnings calls and 12 other investor events across 24 companies, most recently for Teva Pharmaceutical Industries Ltd on October 9, 2026. Those appearances were for Teva Pharmaceutical Industries Ltd (TEVA), Axsome Therapeutics, Inc. (AXSM), Jazz Pharmaceuticals plc (JAZZ), Mineralys Therapeutics, Inc. (MLYS), Fractyl Health, Inc. (GUTS) and 19 other companies. The companies whose calls Jason Gerberry spoke on are classified in the Healthcare sector.

Jason Gerberry on recent calls

“So, for me, I'm just curious, you know, how the sales force is going to be prioritizing the two LAIs now, and will Uzzetti still get a lot of attention, you know, now that there's this new shiny toy in the portfolio?”
Analyst — Bank of America, WELTRUZA™ (olanzapine) Approval – Conference Call ·
“Well, welcome to the next company presenter at the B of A Global Health Care Conference. It's my pleasure to be introducing Teva Pharmaceuticals and President and CEO Richard Francis.”
Analyst — Bank of America, BofA Global Healthcare Conference 2026 ·
“So just thinking about the growth here, is it fair to say that most of the growth is coming from category expansion and limited more on the switch from inhaled competitor agents?”
Analyst — Bank of America, Liquidia Corp Q2 FY2026 Earnings Call ·
“In terms of the early AZ launch, any learnings as you interrogate the data so far in terms of perhaps good, bad, or just too early to formulate any conclusions?”
Analyst — Bank of America, Second Quarter 2026 Earnings Call ·

Affiliation history

  • Bank of America

    Analyst

    Source not stated

    Current

Company network

Recent activity

Show 40 earlier activities